Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Michael L. Eagle currently holds 26,250 shares of Somaxon Pharmaceuticals, Inc. (SOMX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael L. Eagle has been a net buyer of SOMX stock. They have purchased $96.0K and sold $74.8K worth of shares.
Michael L. Eagle's most recent insider trade was on Jul 27, 2016, when they sold 2,625 shares at $4.00 per share.
Michael L. Eagle serves as Executive at Somaxon Pharmaceuticals, Inc. (SOMX). They have executed 20 insider transactions totaling $170.9K over their tenure at the company.
Michael L. Eagle holds the position of Executive at Somaxon Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
Michael L. Eagle has shown a buying trading pattern, with $96.0K in total purchases and $74.8K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Michael L. Eagle was on Dec 1, 2010, when they sold $66.7K worth of SOMX shares. This transaction involved 24,900 shares at $2.68 per share.
Michael L. Eagle currently owns 26,250 shares of Somaxon Pharmaceuticals, Inc. (SOMX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Michael L. Eagle's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Michael L. Eagle has 20 Form 4 filings on record as an insider at Somaxon Pharmaceuticals, Inc..
Set alerts for Michael L. Eagle and 40,000+ other insiders.